Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

about

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

Item

http://www.wikidata.org/entity/Q58597213

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@en

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@nl

type

Item

label

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@en

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@nl

prefLabel

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@en

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@nl

P1476

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

@en

P2093

Aaron T Gomez

http://www.w3.org/2001/XMLSchema#string

Daniel Hofstedt

http://www.w3.org/2001/XMLSchema#string

Lawsen Parker

http://www.w3.org/2001/XMLSchema#string

Majid Moshirfar

http://www.w3.org/2001/XMLSchema#string

Orry C Birdsong

http://www.w3.org/2001/XMLSchema#string

Phillip C Sr Hoopes

http://www.w3.org/2001/XMLSchema#string

Tirth J Shah

http://www.w3.org/2001/XMLSchema#string

Yasmyne C Ronquillo

http://www.w3.org/2001/XMLSchema#string

P2860

Rho GTPases and the actin cytoskeleton

Rho and Rac take center stage

Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits.

The effect of Rho-associated protein kinase inhibitor on monkey Schlemm's canal endothelial cells.

Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.

Ripasudil: first global approval.

The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach

Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy

Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.

Fuchs endothelial corneal dystrophy

P304

101-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386798

http://www.w3.org/2001/XMLSchema#string

P932

6205677

http://www.w3.org/2001/XMLSchema#string